{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:53:40Z","timestamp":1784876020020,"version":"3.55.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00415-022-11200-0","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T10:03:23Z","timestamp":1654250603000},"page":"4646-4662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Movement disorders and neuropathies: overlaps and mimics in clinical practice"],"prefix":"10.1007","volume":"269","author":[{"given":"Francesco","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8874-1070","authenticated-orcid":false,"given":"Tommaso","family":"Bocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"11200_CR1","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1016\/j.nmd.2017.06.531","volume":"27","author":"J Reimann","year":"2017","unstructured":"Reimann J, Paus S (2017) Movement disorders hidden in the neuromuscular clinic. Neuromuscul Disord 27:S243","journal-title":"Neuromuscul Disord"},{"key":"11200_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/practneurol-2015-001311","volume":"16","author":"BR Bloem","year":"2016","unstructured":"Bloem BR, Voermans NC, Aerts MB, Bhatia KP, van Engelen BG, van de Warrenburg BP (2016) The wrong end of the telescope: neuromuscular mimics of movement disorders (and vice versa). Pract Neurol 16:264\u2013269","journal-title":"Pract Neurol"},{"key":"11200_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jns.2017.05.023","volume":"378","author":"P Zis","year":"2017","unstructured":"Zis P, Grunewald RA, Chaudhuri RK, Hadjivassiliou M (2017) Peripheral neuropathy in idiopathic Parkinson\u2019s disease: a systematic review. J Neurol Sci 378:204\u2013209","journal-title":"J Neurol Sci"},{"key":"11200_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.parkreldis.2018.04.006","volume":"54","author":"ML Beaulieu","year":"2018","unstructured":"Beaulieu ML, Muller M, Bohnen NI (2018) Peripheral neuropathy is associated with more frequent falls in Parkinson\u2019s disease. Parkinsonism Relat Disord 54:46\u201350","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR5","doi-asserted-by":"publisher","unstructured":"Corra MF, Vila-Cha N, Sardoeira A, Hansen C, Sousa AP, Reis I, Sambayeta F, Damasio J, Calejo M, Schicketmueller A, Laranjinha I, Salgado P, Taipa R, Magalhaes R, Correia M, Maetzler W, Maia LF (2022) Peripheral neuropathy in Parkinson's disease: prevalence and functional impact on gait and balance. Brain. https:\/\/doi.org\/10.1093\/brain\/awac026","DOI":"10.1093\/brain\/awac026"},{"key":"11200_CR6","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.25585","volume":"28","author":"R Ceravolo","year":"2013","unstructured":"Ceravolo R, Cossu G, Bandettini di Poggio M, Santoro L, Barone P, Zibetti M, Frosini D, Nicoletti V, Manganelli F, Iodice R, Picillo M, Merola A, Lopiano L, Paribello A, Manca D, Melis M, Marchese R, Borelli P, Mereu A, Contu P, Abbruzzese G, Bonuccelli U (2013) Neuropathy and levodopa in Parkinson\u2019s disease: evidence from a multicenter study. Mov Disord 28:1391\u20131397","journal-title":"Mov Disord"},{"key":"11200_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ana.22021","volume":"68","author":"C Toth","year":"2010","unstructured":"Toth C, Breithaupt K, Ge S, Duan Y, Terris JM, Thiessen A, Wiebe S, Zochodne DW, Suchowersky O (2010) Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 68:28\u201336","journal-title":"Ann Neurol"},{"key":"11200_CR8","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","volume":"77","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA, Martey J (2011) Neuropathy in Parkinson disease: prevalence and determinants. Neurology 77:1947\u20131950","journal-title":"Neurology"},{"key":"11200_CR9","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s10072-020-04407-4","volume":"41","author":"DA Paul","year":"2020","unstructured":"Paul DA, Qureshi ARM, Rana AQ (2020) Peripheral neuropathy in Parkinson\u2019s disease. Neurol Sci 41:2691\u20132701","journal-title":"Neurol Sci"},{"key":"11200_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mds.20261","volume":"20","author":"P Lamberti","year":"2005","unstructured":"Lamberti P, Zoccolella S, Iliceto G, Armenise E, Fraddosio A, de Mari M, Livrea P (2005) Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson\u2019s disease patients. Mov Disord 20:69\u201372","journal-title":"Mov Disord"},{"key":"11200_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.parkreldis.2013.08.007","volume":"20","author":"I Galazky","year":"2014","unstructured":"Galazky I, Schoof J, Stallforth S, Kupsch A, Heinze HJ, Kluge C (2014) Guillain-Barre\/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa\/carbidopa treatment. Parkinsonism Relat Disord 20:125\u2013127","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR12","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/mds.22807","volume":"24","author":"D Manca","year":"2009","unstructured":"Manca D, Cossu G, Murgia D, Molari A, Ferrigno P, Marcia E, Melis M (2009) Reversible encephalopathy and axonal neuropathy in Parkinson\u2019s disease during duodopa therapy. Mov Disord 24:2293\u20132294","journal-title":"Mov Disord"},{"key":"11200_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ene.12846","volume":"23","author":"A Merola","year":"2016","unstructured":"Merola A, Romagnolo A, Zibetti M, Bernardini A, Cocito D, Lopiano L (2016) Peripheral neuropathy associated with levodopa\u2013carbidopa intestinal infusion: a long-term prospective assessment. Eur J Neurol 23:501\u2013509","journal-title":"Eur J Neurol"},{"key":"11200_CR14","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/mds.23342","volume":"25","author":"PP Urban","year":"2010","unstructured":"Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, Knop K, Weis J (2010) Subacute axonal neuropathy in Parkinson\u2019s disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 25:1748\u20131752","journal-title":"Mov Disord"},{"key":"11200_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10072-014-1898-y","volume":"36","author":"J Domingos","year":"2015","unstructured":"Domingos J, Coelho T, Taipa R, Basto JP, Melo-Pires M, Magalhaes MJ (2015) PARK2 presenting as a disabling peripheral axonal neuropathy. Neurol Sci 36:341\u2013343","journal-title":"Neurol Sci"},{"key":"11200_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1353-8020(02)00114-1","volume":"9","author":"Y Okuma","year":"2003","unstructured":"Okuma Y, Hattori N, Mizuno Y (2003) Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2). Parkinsonism Relat Disord 9:313\u2013314","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fneur.2019.00111","volume":"10","author":"M Jeziorska","year":"2019","unstructured":"Jeziorska M, Atkinson A, Kass-Iliyya L, Javed S, Kobylecki C, Gosal D, Marshall A, Silverdale M, Malik RA (2019) Increased intraepidermal nerve fiber degeneration and impaired regeneration relate to symptoms and deficits in Parkinson\u2019s disease. Front Neurol 10:111","journal-title":"Front Neurol"},{"key":"11200_CR18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1212\/WNL.0000000000004274","volume":"89","author":"M Nolano","year":"2017","unstructured":"Nolano M, Provitera V, Manganelli F, Iodice R, Stancanelli A, Caporaso G, Saltalamacchia A, Califano F, Lanzillo B, Picillo M, Barone P, Santoro L (2017) Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients. Neurology 89:776\u2013784","journal-title":"Neurology"},{"key":"11200_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/practneurol-2013-000758","volume":"14","author":"AC Themistocleous","year":"2014","unstructured":"Themistocleous AC, Ramirez JD, Serra J, Bennett DL (2014) The clinical approach to small fibre neuropathy and painful channelopathy. Pract Neurol 14:368\u2013379","journal-title":"Pract Neurol"},{"key":"11200_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.03.007","volume":"64","author":"X Xu","year":"2019","unstructured":"Xu X, Liao J, Dong Q, Qin F, Li J, Sun X, Lu T, Fang L, Peng F, Lu Z, Qiu W (2019) Clinical utility of SUDOSCAN in predicting autonomic neuropathy in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 64:60\u201365","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.parkreldis.2019.05.038","volume":"65","author":"M Carmona-Abellan","year":"2019","unstructured":"Carmona-Abellan M, Gabilondo I, Murueta-Goyena A, Khurana V, Tijero B, Luquin MR, Acera M, Del Pino R, Gardeazabal J, Martinez-Valbuena I, Sanchez-Pernaute R, Gomez-Esteban JC (2019) Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers. Parkinsonism Relat Disord 65:139\u2013145","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR22","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","volume":"82","author":"V Donadio","year":"2014","unstructured":"Donadio V, Incensi A, Leta V, Giannoccaro MP, Scaglione C, Martinelli P, Capellari S, Avoni P, Baruzzi A, Liguori R (2014) Skin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology 82:1362\u20131369","journal-title":"Neurology"},{"key":"11200_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/mdc3.13321","volume":"8","author":"E Donlon","year":"2021","unstructured":"Donlon E, Lynch R, Murphy OC, Farrell M, Noel J, Keogan M, O\u2019Connell M, Lynch T (2021) Braak\u2019s unfinished hypothesis: a clinicopathological case report of alpha-synuclein peripheral neuropathy preceding Parkinsonism by 20\u00a0years. Mov Disord Clin Pract 8:1129\u20131133","journal-title":"Mov Disord Clin Pract"},{"key":"11200_CR24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/acn3.51301","volume":"8","author":"J Yang","year":"2021","unstructured":"Yang J, Wang H, Yuan Y, Fan S, Li L, Jiang C, Mao C, Shi C, Xu Y (2021) Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants. Ann Clin Transl Neurol 8:592\u2013602","journal-title":"Ann Clin Transl Neurol"},{"key":"11200_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2018.10.003","volume":"60","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhu L, Sun L, Zhi Y, Ding J, Yuan YS, Shen FF, Li X, Ji P, Wang Z, Niu Q, Zhang KZ (2019) Phosphorylated alpha-synuclein deposits in sural nerve deriving from Schwann cells: a biomarker for Parkinson\u2019s disease. Parkinsonism Relat Disord 60:57\u201363","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1212\/WNL.0000000000004146","volume":"89","author":"V Donadio","year":"2017","unstructured":"Donadio V, Incensi A, Rizzo G, Capellari S, Pantieri R, Stanzani Maserati M, Devigili G, Eleopra R, Defazio G, Montini F, Baruzzi A, Liguori R (2017) A new potential biomarker for dementia with Lewy bodies: Skin nerve alpha-synuclein deposits. Neurology 89:318\u2013326","journal-title":"Neurology"},{"key":"11200_CR27","doi-asserted-by":"publisher","first-page":"e2513","DOI":"10.1212\/WNL.0000000000011935","volume":"96","author":"V Donadio","year":"2021","unstructured":"Donadio V, Wang Z, Incensi A, Rizzo G, Fileccia E, Vacchiano V, Capellari S, Magnani M, Scaglione C, Stanzani Maserati M, Avoni P, Liguori R, Zou W (2021) In vivo diagnosis of synucleinopathies: a comparative study of skin biopsy and RT-QuIC. Neurology 96:e2513\u2013e2524","journal-title":"Neurology"},{"key":"11200_CR28","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","volume":"90","author":"D Dubey","year":"2018","unstructured":"Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ (2018) Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases. Neurology 90:e103\u2013e110","journal-title":"Neurology"},{"key":"11200_CR29","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.10518","volume":"53","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580\u2013587","journal-title":"Ann Neurol"},{"key":"11200_CR30","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J Dalmau","year":"2004","unstructured":"Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P, Rosenfeld MR (2004) Clinical analysis of anti-Ma2-associated encephalitis. Brain 127:1831\u20131844","journal-title":"Brain"},{"key":"11200_CR31","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/01.wnl.0000252379.81933.80","volume":"68","author":"RM Mathew","year":"2007","unstructured":"Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, Rosenfeld MR, Rossi JE, Thiessen B, Dropcho EJ, Dalmau J (2007) Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 68:900\u2013905","journal-title":"Neurology"},{"key":"11200_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mus.24943","volume":"53","author":"KG Gwathmey","year":"2016","unstructured":"Gwathmey KG (2016) Sensory neuronopathies. Muscle Nerve 53:8\u201319","journal-title":"Muscle Nerve"},{"key":"11200_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/mus.23502","volume":"46","author":"L Sharp","year":"2012","unstructured":"Sharp L, Vernino S (2012) Paraneoplastic neuromuscular disorders. Muscle Nerve 46:841\u2013850","journal-title":"Muscle Nerve"},{"key":"11200_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241\u2013255","journal-title":"Ann Neurol"},{"key":"11200_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","volume":"385","author":"JF Baizabal-Carvallo","year":"2018","unstructured":"Baizabal-Carvallo JF, Jankovic J (2018) Autoimmune and paraneoplastic movement disorders: an update. J Neurol Sci 385:175\u2013184","journal-title":"J Neurol Sci"},{"key":"11200_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1055\/s-0028-1082273","volume":"34","author":"W Miesbach","year":"2008","unstructured":"Miesbach W (2008) Neurologic symptoms as a feature of the antiphospholipid syndrome. Semin Thromb Hemost 34:286\u2013289","journal-title":"Semin Thromb Hemost"},{"key":"11200_CR37","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","volume":"120","author":"JF Baizabal-Carvallo","year":"2013","unstructured":"Baizabal-Carvallo JF, Bonnet C, Jankovic J (2013) Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm 120:1579\u20131589","journal-title":"J Neural Transm"},{"key":"11200_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055843","volume":"8","author":"EI Kampylafka","year":"2013","unstructured":"Kampylafka EI, Alexopoulos H, Kosmidis ML, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, Moutsopoulos HM, Tzioufas AG (2013) Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS ONE 8:e55843","journal-title":"PLoS ONE"},{"key":"11200_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","volume":"76","author":"R Cervera","year":"1997","unstructured":"Cervera R, Asherson RA, Font J, Tikly M, Pallares L, Chamorro A, Ingelmo M (1997) Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 76:203\u2013212","journal-title":"Medicine (Baltimore)"},{"key":"11200_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/B978-0-444-52014-2.00016-1","volume":"100","author":"EK Plowman","year":"2011","unstructured":"Plowman EK, Okun MS (2011) Antiphospholipid syndrome and other lupus-related movement disorders. Handb Clin Neurol 100:237\u2013245","journal-title":"Handb Clin Neurol"},{"key":"11200_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/brain\/awab285","volume":"145","author":"N Riva","year":"2022","unstructured":"Riva N, Gentile F, Cerri F, Gallia F, Podini P, Dina G, Falzone YM, Fazio R, Lunetta C, Calvo A, Logroscino G, Lauria G, Corbo M, Iannaccone S, Chio A, Lazzerini A, Nobile-Orazio E, Filippi M, Quattrini A (2022) Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis. Brain 145:276\u2013284","journal-title":"Brain"},{"key":"11200_CR42","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.38302","volume":"66","author":"A Oomatia","year":"2014","unstructured":"Oomatia A, Fang H, Petri M, Birnbaum J (2014) Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period. Arthritis Rheumatol 66:1000\u20131009","journal-title":"Arthritis Rheumatol"},{"key":"11200_CR43","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.neurol.2012.03.010","volume":"168","author":"L Lachhab","year":"2012","unstructured":"Lachhab L, Regragui W, Hamaz S, Ait Benhaddou EH, Benomar A, Yahyaoui M (2012) Parkinsonism as first manifestation of lupus. Rev Neurol (Paris) 168:990\u2013991","journal-title":"Rev Neurol (Paris)"},{"key":"11200_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/07853890.2017.1412088","volume":"50","author":"CC Chang","year":"2018","unstructured":"Chang CC, Lin TM, Chang YS, Chen WS, Sheu JJ, Chen YH, Chen JH (2018) Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan. Ann Med 50:83\u201390","journal-title":"Ann Med"},{"key":"11200_CR45","first-page":"856","volume":"46","author":"JD Wang","year":"1989","unstructured":"Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS (1989) Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 46:856\u2013859","journal-title":"Br J Ind Med"},{"key":"11200_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/mds.870120532","volume":"12","author":"CC Huang","year":"1997","unstructured":"Huang CC, Chu NS, Lu CS, Calne DB (1997) Cock gait in manganese intoxication. Mov Disord 12:807\u2013808","journal-title":"Mov Disord"},{"key":"11200_CR47","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archneur.1989.00520460090018","volume":"46","author":"CC Huang","year":"1989","unstructured":"Huang CC, Chu NS, Lu CS, Wang JD, Tsai JL, Tzeng JL, Wolters EC, Calne DB (1989) Chronic manganese intoxication. Arch Neurol 46:1104\u20131106","journal-title":"Arch Neurol"},{"key":"11200_CR48","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1056\/NEJM199703273361319","volume":"336","author":"A Arjona","year":"1997","unstructured":"Arjona A, Mata M, Bonet M (1997) Diagnosis of chronic manganese intoxication by magnetic resonance imaging. N Engl J Med 336:964\u2013965","journal-title":"N Engl J Med"},{"key":"11200_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1212\/WNL.43.8.1479","volume":"43","author":"CC Huang","year":"1993","unstructured":"Huang CC, Lu CS, Chu NS, Hochberg F, Lilienfeld D, Olanow W, Calne DB (1993) Progression after chronic manganese exposure. Neurology 43:1479\u20131483","journal-title":"Neurology"},{"key":"11200_CR50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.neuro.2007.05.003","volume":"28","author":"OP Soldin","year":"2007","unstructured":"Soldin OP, Aschner M (2007) Effects of manganese on thyroid hormone homeostasis: potential links. Neurotoxicology 28:951\u2013956","journal-title":"Neurotoxicology"},{"key":"11200_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1600-0404.1998.tb07331.x","volume":"98","author":"CC Chu","year":"1998","unstructured":"Chu CC, Huang CC, Ryu SJ, Wu TN (1998) Chronic inorganic mercury induced peripheral neuropathy. Acta Neurol Scand 98:461\u2013465","journal-title":"Acta Neurol Scand"},{"key":"11200_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1750-1172-6-68","volume":"6","author":"HH Jung","year":"2011","unstructured":"Jung HH, Danek A, Walker RH (2011) Neuroacanthocytosis syndromes. Orphanet J Rare Dis 6:68","journal-title":"Orphanet J Rare Dis"},{"key":"11200_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/mds.22863","volume":"25","author":"B Bader","year":"2010","unstructured":"Bader B, Walker RH, Vogel M, Prosiegel M, McIntosh J, Danek A (2010) Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. Mov Disord 25:127\u2013129","journal-title":"Mov Disord"},{"key":"11200_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978-0-444-52014-2.00007-0","volume":"100","author":"RH Walker","year":"2011","unstructured":"Walker RH, Jung HH, Danek A (2011) Neuroacanthocytosis. Handb Clin Neurol 100:141\u2013151","journal-title":"Handb Clin Neurol"},{"key":"11200_CR55","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/mus.1154","volume":"24","author":"HH Jung","year":"2001","unstructured":"Jung HH, Russo D, Redman C, Brandner S (2001) Kell and XK immunohistochemistry in McLeod myopathy. Muscle Nerve 24:1346\u20131351","journal-title":"Muscle Nerve"},{"key":"11200_CR56","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/mds.1188","volume":"16","author":"A Danek","year":"2001","unstructured":"Danek A, Tison F, Rubio J, Oechsner M, Kalckreuth W, Monaco AP (2001) The chorea of McLeod syndrome. Mov Disord 16:882\u2013889","journal-title":"Mov Disord"},{"key":"11200_CR57","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/14734220510007914","volume":"4","author":"MU Manto","year":"2005","unstructured":"Manto MU (2005) The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 4:2\u20136","journal-title":"Cerebellum"},{"key":"11200_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/125273","volume":"2015","author":"H Park","year":"2015","unstructured":"Park H, Kim HJ, Jeon BS (2015) Parkinsonism in spinocerebellar ataxia. Biomed Res Int 2015:125273","journal-title":"Biomed Res Int"},{"key":"11200_CR59","doi-asserted-by":"crossref","unstructured":"Charles P, Camuzat A, Benammar N, Sellal F, Destee A, Bonnet AM, Lesage S, Le Ber I, Stevanin G, Durr A, Brice A, French Parkinson's Disease Genetic Study G (2007) Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology 69:1970\u20131975","DOI":"10.1212\/01.wnl.0000269323.21969.db"},{"key":"11200_CR60","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.0b013e3181a18876","volume":"72","author":"JY Kim","year":"2009","unstructured":"Kim JY, Kim SY, Kim JM, Kim YK, Yoon KY, Kim JY, Lee BC, Kim JS, Paek SH, Park SS, Kim SE, Jeon BS (2009) Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism. Neurology 72:1385\u20131389","journal-title":"Neurology"},{"key":"11200_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neulet.2006.04.019","volume":"403","author":"SW Lim","year":"2006","unstructured":"Lim SW, Zhao Y, Chua E, Law HY, Yuen Y, Pavanni R, Wong MC, Ng IS, Yoon CS, Puong KY, Lim SH, Tan EK (2006) Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson\u2019s disease. Neurosci Lett 403:11\u201314","journal-title":"Neurosci Lett"},{"key":"11200_CR62","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1007\/s00415-012-6531-5","volume":"259","author":"C Bonnet","year":"2012","unstructured":"Bonnet C, Apartis E, Anheim M, Legrand AP, Baizabal-Carvallo JF, Bonnet AM, Durr A, Vidailhet M (2012) Tremor-spectrum in spinocerebellar ataxia type 3. J Neurol 259:2460\u20132470","journal-title":"J Neurol"},{"key":"11200_CR63","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-444-63233-3.00018-X","volume":"147","author":"MT Lorincz","year":"2018","unstructured":"Lorincz MT (2018) Wilson disease and related copper disorders. Handb Clin Neurol 147:279\u2013292","journal-title":"Handb Clin Neurol"},{"key":"11200_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"O Bandmann","year":"2015","unstructured":"Bandmann O, Weiss KH, Kaler SG (2015) Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol 14:103\u2013113","journal-title":"Lancet Neurol"},{"key":"11200_CR65","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1001\/archneur.62.10.1628","volume":"62","author":"KH Jung","year":"2005","unstructured":"Jung KH, Ahn TB, Jeon BS (2005) Wilson disease with an initial manifestation of polyneuropathy. Arch Neurol 62:1628\u20131631","journal-title":"Arch Neurol"},{"key":"11200_CR66","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1167\/iovs.14-15004","volume":"56","author":"GC Sturniolo","year":"2015","unstructured":"Sturniolo GC, Lazzarini D, Bartolo O, Berton M, Leonardi A, Fregona IA, Parrozzani R, Midena E (2015) Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy. Invest Ophthalmol Vis Sci 56:1390\u20131395","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11200_CR67","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000119","volume":"2","author":"B Bansagi","year":"2016","unstructured":"Bansagi B, Lewis-Smith D, Pal E, Duff J, Griffin H, Pyle A, Muller JS, Rudas G, Aranyi Z, Lochmuller H, Chinnery PF, Horvath R (2016) Phenotypic convergence of Menkes and Wilson disease. Neurol Genet 2:e119","journal-title":"Neurol Genet"},{"key":"11200_CR68","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/jnnp-2012-303013","volume":"84","author":"TA Saifee","year":"2013","unstructured":"Saifee TA, Schwingenschuh P, Reilly MM, Lunn MP, Katschnig P, Kassavetis P, Parees I, Manji H, Bhatia K, Rothwell JC, Edwards MJ (2013) Tremor in inflammatory neuropathies. J Neurol Neurosurg Psychiatry 84:1282\u20131287","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11200_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jnnp-2017-316715","volume":"89","author":"J Svahn","year":"2018","unstructured":"Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Leger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanche JP, Francophone anti MAGcG, (2018) Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features. J Neurol Neurosurg Psychiatry 89:499\u2013505","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 4","key":"11200_CR70","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/brain\/123.4.710","volume":"123","author":"E Nobile-Orazio","year":"2000","unstructured":"Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G (2000) Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 123(Pt 4):710\u2013717","journal-title":"Brain"},{"key":"11200_CR71","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","volume":"86","author":"JJ Devaux","year":"2016","unstructured":"Devaux JJ, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M, Sekiguchi K, Kokubun N, Ichikawa H, Wong AH, Yuki N (2016) Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology 86:800\u2013807","journal-title":"Neurology"},{"key":"11200_CR72","doi-asserted-by":"publisher","first-page":"e2392","DOI":"10.1212\/WNL.0000000000012932","volume":"97","author":"S Shelly","year":"2021","unstructured":"Shelly S, Klein CJ, Dyck PJB, Paul P, Mauermann ML, Berini SE, Howe B, Fryer JP, Basal E, Bakri HM, Laughlin RS, McKeon A, Pittock SJ, Mills J, Dubey D (2021) Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology 97:e2392\u2013e2403","journal-title":"Neurology"},{"issue":"6","key":"11200_CR73","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1007\/s10072-021-05811-0","volume":"43","author":"G Liberatore","year":"2022","unstructured":"Liberatore G, De Lorenzo A, Giannotta C, Manganelli F, Filosto M, Cosentino G, Cocito D, Briani C, Cortese A, Fazio R, Lauria G, Clerici AM, Rosso T, Marfia GA, Antonini G, Cavaletti G, Carpo M, Doneddu PE, Spina E, Cotti Piccinelli S, Peci E, Querol L, Nobile-Orazio E (2022) Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database. Neurol Sci 43(6):3939\u20133947","journal-title":"Neurol Sci"},{"key":"11200_CR74","doi-asserted-by":"crossref","unstructured":"Martin-Aguilar L, Lleixa C, Pascual-Goni E, Caballero-Avila M, Martinez-Martinez L, Diaz-Manera J, Rojas-Garcia R, Cortes-Vicente E, Turon-Sans J, de Luna N, Suarez-Calvet X, Gallardo E, Rajabally Y, Scotton S, Jacobs BC, Baars A, Cortese A, Vegezzi E, Hoftberger R, Zimprich F, Roesler C, Nobile-Orazio E, Liberatore G, Hiew FL, Martinez-Pineiro A, Carvajal A, Pinar-Morales R, Uson-Martin M, Alberti O, Lopez-Perez MA, Marquez F, Pardo-Fernandez J, Munoz-Delgado L, Cabrera-Serrano M, Ortiz N, Bartolome M, Duman O, Bril V, Segura-Chavez D, Pitarokoili K, Steen C, Illa I, Querol L (2022) Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy. Neurol Neuroimmunol Neuroinflamm 9:e1098","DOI":"10.1212\/NXI.0000000000001098"},{"issue":"Suppl","key":"11200_CR75","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ana.410090719","volume":"9","author":"MC Dalakas","year":"1981","unstructured":"Dalakas MC, Engel WK (1981) Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 9(Suppl):134\u2013145","journal-title":"Ann Neurol"},{"key":"11200_CR76","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/archneur.1984.04050180033012","volume":"41","author":"MC Dalakas","year":"1984","unstructured":"Dalakas MC, Teravainen H, Engel WK (1984) Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management Arch Neurol 41:711\u2013714","journal-title":"Incidence and management Arch Neurol"},{"key":"11200_CR77","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00415-003-1068-2","volume":"250","author":"M Busby","year":"2003","unstructured":"Busby M, Donaghy M (2003) Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol 250:714\u2013724","journal-title":"J Neurol"},{"key":"11200_CR78","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1212\/WNL.0b013e318292a2b8","volume":"80","author":"P Schwingenschuh","year":"2013","unstructured":"Schwingenschuh P, Saifee TA, Katschnig-Winter P, Reilly MM, Lunn MP, Manji H, Aguirregomozcorta M, Schmidt R, Bhatia KP, Rothwell JC, Edwards MJ (2013) Cerebellar learning distinguishes inflammatory neuropathy with and without tremor. Neurology 80:1867\u20131873","journal-title":"Neurology"},{"key":"11200_CR79","first-page":"423","volume":"42","author":"D Brooks","year":"1992","unstructured":"Brooks D, Jenkins I, Bain P, Colebatch J, Thompson P, Findley L, Marsden C (1992) A comparison of the abnormal patterns of cerebral activation associated with neuropathic and essential tremor. Neurology 42:423","journal-title":"Neurology"},{"key":"11200_CR80","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00415-017-8675-9","volume":"265","author":"P Zis","year":"2018","unstructured":"Zis P, Rao DG, Hoggard N, Sarrigiannis PG, Hadjivassiliou M (2018) Anti-MAG associated cerebellar ataxia and response to rituximab. J Neurol 265:115\u2013118","journal-title":"J Neurol"},{"key":"11200_CR81","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.parkreldis.2020.06.027","volume":"77","author":"M Zech","year":"2020","unstructured":"Zech M, Brunet T, Skorvanek M, Blaschek A, Vill K, Hanker B, Huning I, Han V, Dosekova P, Gdovinova Z, Alhaddad B, Berutti R, Strom TM, Ruzicka E, Kamsteeg EJ, van der Smagt JJ, Wagner M, Jech R, Winkelmann J (2020) Recessive null-allele variants in MAG associated with spastic ataxia, nystagmus, neuropathy, and dystonia. Parkinsonism Relat Disord 77:70\u201375","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR82","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2019.02.045","volume":"63","author":"E Monfrini","year":"2019","unstructured":"Monfrini E, Straniero L, Bonato S, Monzio Compagnoni G, Bordoni A, Dilena R, Rinchetti P, Silipigni R, Ronchi D, Corti S, Comi GP, Bresolin N, Duga S, Di Fonzo A (2019) Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy. Parkinsonism Relat Disord 63:66\u201372","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR83","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/mdc3.12336","volume":"4","author":"N Garg","year":"2017","unstructured":"Garg N, Heard RNS, Kiers L, Gerraty R, Yiannikas C (2017) Multifocal motor neuropathy presenting as pseudodystonia. Mov Disord Clin Pract 4:100\u2013104","journal-title":"Mov Disord Clin Pract"},{"key":"11200_CR84","first-page":"915","volume-title":"Handbook of clinical neurology","author":"N Kumar","year":"2014","unstructured":"Kumar N (2014) Chapter 60\u2014Neurologic aspects of cobalamin (B12) deficiency. In: Biller J, Ferro JM (eds) Handbook of clinical neurology. Elsevier, pp 915\u2013926"},{"key":"11200_CR85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1056\/NEJMcp1113996","volume":"368","author":"SP Stabler","year":"2013","unstructured":"Stabler SP (2013) Clinical practice. Vitamin B12 deficiency. N Engl J Med 368:149\u2013160","journal-title":"N Engl J Med"},{"key":"11200_CR86","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","volume":"5","author":"E Reynolds","year":"2006","unstructured":"Reynolds E (2006) Vitamin B12, folic acid, and the nervous system. Lancet Neurol 5:949\u2013960","journal-title":"Lancet Neurol"},{"key":"11200_CR87","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s10072-019-03918-z","volume":"40","author":"SK Bhoi","year":"2019","unstructured":"Bhoi SK, Jha M, Naik S, Palo GD (2019) Knuckle pigmentation, peripheral neuropathy, madness and abnormal movement: is it B12 deficiency? Neurol Sci 40:2399\u20132401","journal-title":"Neurol Sci"},{"key":"11200_CR88","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1179\/1743132814Y.0000000396","volume":"36","author":"A de Souza","year":"2014","unstructured":"de Souza A, Moloi MW (2014) Involuntary movements due to vitamin B12 deficiency. Neurol Res 36:1121\u20131128","journal-title":"Neurol Res"},{"key":"11200_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251642","volume":"16","author":"M Yovera-Aldana","year":"2021","unstructured":"Yovera-Aldana M, Velasquez-Rimachi V, Huerta-Rosario A, More-Yupanqui MD, Osores-Flores M, Espinoza R, Gil-Olivares F, Quispe-Nolazco C, Quea-Velez F, Moran-Marinos C, Pinedo-Torres I, Alva-Diaz C, Pacheco-Barrios K (2021) Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: a systematic review and meta-analysis. PLoS ONE 16:e0251642","journal-title":"PLoS ONE"},{"key":"11200_CR90","doi-asserted-by":"publisher","first-page":"402","DOI":"10.5334\/tohm.291","volume":"6","author":"C Cosentino","year":"2016","unstructured":"Cosentino C, Torres L, Nunez Y, Suarez R, Velez M, Flores M (2016) Hemichorea\/hemiballism associated with hyperglycemia: report of 20 cases. Tremor Other Hyperkinet Mov 6:402","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"11200_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-510X(02)00133-8","volume":"200","author":"SH Oh","year":"2002","unstructured":"Oh SH, Lee KY, Im JH, Lee MS (2002) Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases. J Neurol Sci 200:57\u201362","journal-title":"J Neurol Sci"},{"key":"11200_CR92","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/hdi.12587","volume":"22","author":"B Jabbari","year":"2018","unstructured":"Jabbari B, Vaziri ND (2018) The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial Int 22:150\u2013160","journal-title":"Hemodial Int"},{"key":"11200_CR93","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jns.2015.08.002","volume":"357","author":"JW Park","year":"2015","unstructured":"Park JW, Kim SU, Choi JY, Jung JM, Kwon DY, Park MH (2015) Reversible parkinsonism with lentiform fork sign as an initial and dominant manifestation of uremic encephalopathy. J Neurol Sci 357:343\u2013344","journal-title":"J Neurol Sci"},{"key":"11200_CR94","first-page":"38","volume":"15","author":"MR Jones","year":"2020","unstructured":"Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, Williamson A, Viswanath O (2020) Drug-induced peripheral neuropathy: a narrative review. Curr Clin Pharmacol 15:38\u201348","journal-title":"Curr Clin Pharmacol"},{"key":"11200_CR95","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1474-4422(05)70250-7","volume":"4","author":"JC Morgan","year":"2005","unstructured":"Morgan JC, Sethi KD (2005) Drug-induced tremors. Lancet Neurol 4:866\u2013876","journal-title":"Lancet Neurol"},{"key":"11200_CR96","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/mds.10344","volume":"18","author":"C Chuang","year":"2003","unstructured":"Chuang C, Constantino A, Balmaceda C, Eidelberg D, Frucht SJ (2003) Chemotherapy-induced parkinsonism responsive to levodopa: an underrecognized entity. Mov Disord 18:328\u2013331","journal-title":"Mov Disord"},{"key":"11200_CR97","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mus.880160904","volume":"16","author":"FE Cardoso","year":"1993","unstructured":"Cardoso FE, Jankovic J (1993) Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve 16:904\u2013910","journal-title":"Muscle Nerve"},{"key":"11200_CR98","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1474-4422(13)70158-3","volume":"12","author":"D Pareyson","year":"2013","unstructured":"Pareyson D, Piscosquito G, Moroni I, Salsano E, Zeviani M (2013) Peripheral neuropathy in mitochondrial disorders. Lancet Neurol 12:1011\u20131024","journal-title":"Lancet Neurol"},{"key":"11200_CR99","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/acn3.281","volume":"3","author":"MB Aerts","year":"2016","unstructured":"Aerts MB, Weterman MA, Quadri M, Schelhaas HJ, Bloem BR, Esselink RA, Baas F, Bonifati V, van de Warrenburg BP (2016) A LRSAM1 mutation links Charcot-Marie-Tooth type 2 to Parkinson\u2019s disease. Ann Clin Transl Neurol 3:146\u2013149","journal-title":"Ann Clin Transl Neurol"},{"key":"11200_CR100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.parkreldis.2020.03.021","volume":"74","author":"M Zimmermann","year":"2020","unstructured":"Zimmermann M, Schuster S, Boesch S, Korenke GC, Mohr J, Reichbauer J, Kernstock C, Kotzot D, Spahlinger V, Schule-Freyer R, Schols L (2020) FIG4 mutations leading to parkinsonism and a phenotypical continuum between CMT4J and Yunis Varon syndrome. Parkinsonism Relat Disord 74:6\u201311","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR101","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2020.10.011","volume":"81","author":"IJ Posada","year":"2020","unstructured":"Posada IJ, Dominguez-Gonzalez C (2020) CMT4J, parkinsonism and a new FIG4 mutation. Parkinsonism Relat Disord 81:82\u201383","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR102","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/mdc3.13139","volume":"8","author":"S Raju","year":"2021","unstructured":"Raju S, Medarametla S, Boraiah N (2021) Dystonia and hereditary motor sensory neuropathy 6B due to SLC25A46 gene mutations. Mov Disord Clin Pract 8:480\u2013482","journal-title":"Mov Disord Clin Pract"},{"key":"11200_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2020.03.018","volume":"74","author":"G Bitetto","year":"2020","unstructured":"Bitetto G, Malaguti MC, Ceravolo R, Monfrini E, Straniero L, Morini A, Di Giacopo R, Frosini D, Palermo G, Biella F, Ronchi D, Duga S, Taroni F, Corti S, Comi GP, Bresolin N, Giometto B, Di Fonzo A (2020) SLC25A46 mutations in patients with Parkinson\u2019s disease and optic atrophy. Parkinsonism Relat Disord 74:1\u20135","journal-title":"Parkinsonism Relat Disord"},{"key":"11200_CR104","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<881::AID-MUS13>3.0.CO;2-V","volume":"20","author":"A Shaibani","year":"1997","unstructured":"Shaibani A, Gooch C, Harati Y (1997) Moving toes and myoclonus associated with hereditary neuropathy with liability to pressure palsy (HNPP). Muscle Nerve 20:881\u2013883","journal-title":"Muscle Nerve"},{"key":"11200_CR105","first-page":"279","volume":"31","author":"M Macovei","year":"1993","unstructured":"Macovei M, Alexianu M, Vasilescu C, Alexianu ME, Dan A, Burghelea B (1993) Chronic sensorimotor polyneuropathy associated with cerebello-extrapyramidal manifestations in a patient with tomaculous neuropathy. Rom J Neurol Psychiatry 31:279\u2013281","journal-title":"Rom J Neurol Psychiatry"},{"key":"11200_CR106","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/mds.870070217","volume":"7","author":"J Kulisevsky","year":"1992","unstructured":"Kulisevsky J, Marti-Fabregas J, Escartin A, Pradas J (1992) Brachial plexus palsy associated with spasmodic torticollis in a patient with tomaculous neuropathy. Mov Disord 7:186\u2013187","journal-title":"Mov Disord"},{"key":"11200_CR107","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1007\/s10072-020-04962-w","volume":"42","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang H, Liu W, Wang J, Zhang J, Chang X, Huang S, Pang X, Guo J, Wang Q, Zhang W (2021) A novel Q93H missense mutation in DCTN1 caused distal hereditary motor neuropathy type 7B and Perry syndrome from a Chinese family. Neurol Sci 42:3695\u20133705","journal-title":"Neurol Sci"},{"key":"11200_CR108","doi-asserted-by":"crossref","unstructured":"Gallo JM, Leigh PN (2007) Chapter 8 Spinobulbar muscular atrophy (Kennedy's disease). Handb Clin Neurol 82:155\u2013169","DOI":"10.1016\/S0072-9752(07)80011-X"},{"key":"11200_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2019.105426","volume":"184","author":"J Finsterer","year":"2019","unstructured":"Finsterer J, Scorza FA (2019) Central nervous system abnormalities in spinal and bulbar muscular atrophy (Kennedy\u2019s disease). Clin Neurol Neurosurg 184:105426","journal-title":"Clin Neurol Neurosurg"},{"key":"11200_CR110","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/B978-0-12-802395-2.00010-9","volume":"145","author":"MJ Molnar","year":"2017","unstructured":"Molnar MJ, Kovacs GG (2017) Mitochondrial diseases. Handb Clin Neurol 145:147\u2013155","journal-title":"Handb Clin Neurol"},{"key":"11200_CR111","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(21)00098-3","volume":"20","author":"YS Ng","year":"2021","unstructured":"Ng YS, Bindoff LA, Gorman GS, Klopstock T, Kornblum C, Mancuso M, McFarland R, Sue CM, Suomalainen A, Taylor RW, Thorburn DR, Turnbull DM (2021) Mitochondrial disease in adults: recent advances and future promise. Lancet Neurol 20:573\u2013584","journal-title":"Lancet Neurol"},{"key":"11200_CR112","doi-asserted-by":"crossref","unstructured":"Hudson G, Chinnery PF (2006) Mitochondrial DNA polymerase-gamma and human disease. Hum Mol Genet 15 Spec No 2:R244\u2013252","DOI":"10.1093\/hmg\/ddl233"},{"key":"11200_CR113","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nmd.2007.11.005","volume":"18","author":"PF Chinnery","year":"2008","unstructured":"Chinnery PF, Zeviani M (2008) 155th ENMC workshop: polymerase gamma and disorders of mitochondrial DNA synthesis, 21\u201323 September 2007, Naarden, The Netherlands. Neuromuscul Disord 18:259\u2013267","journal-title":"Neuromuscul Disord"},{"key":"11200_CR114","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.nmd.2016.02.008","volume":"26","author":"M Mancuso","year":"2016","unstructured":"Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, Federico A, Minetti C, Moggio M, Mongini T, Tonin P, Toscano A, Bruno C, Ienco EC, Filosto M, Lamperti C, Diodato D, Moroni I, Musumeci O, Pegoraro E, Spinazzi M, Ahmed N, Sciacco M, Vercelli L, Ardissone A, Zeviani M, Siciliano G (2016) \u201cMitochondrial neuropathies\u201d: a survey from the large cohort of the Italian Network. Neuromuscul Disord 26:272\u2013276","journal-title":"Neuromuscul Disord"},{"key":"11200_CR115","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1445-5994.2012.02847.x","volume":"43","author":"P Woodbridge","year":"2013","unstructured":"Woodbridge P, Liang C, Davis RL, Vandebona H, Sue CM (2013) POLG mutations in Australian patients with mitochondrial disease. Intern Med J 43:150\u2013156","journal-title":"Intern Med J"},{"key":"11200_CR116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.14802\/jmd.20159","volume":"14","author":"J Qiu","year":"2021","unstructured":"Qiu J, Kumar KR, Watson E, Ahmad K, Sue CM, Hayes MW (2021) Dystonia responsive to dopamine: POLG mutations should be considered if sensory neuropathy is present. J Mov Disord 14:157\u2013160","journal-title":"J Mov Disord"},{"key":"11200_CR117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12031-010-9488-9","volume":"44","author":"D Orsucci","year":"2011","unstructured":"Orsucci D, Caldarazzo Ienco E, Mancuso M, Siciliano G (2011) POLG1-related and other \u201cmitochondrial Parkinsonisms\u201d: an overview. J Mol Neurosci 44:17\u201324","journal-title":"J Mol Neurosci"},{"key":"11200_CR118","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamaneurol.2016.0355","volume":"73","author":"MH Martikainen","year":"2016","unstructured":"Martikainen MH, Ng YS, Gorman GS, Alston CL, Blakely EL, Schaefer AM, Chinnery PF, Burn DJ, Taylor RW, McFarland R, Turnbull DM (2016) Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease. JAMA Neurol 73:668\u2013674","journal-title":"JAMA Neurol"},{"key":"11200_CR119","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.661","volume":"6","author":"MG Otero","year":"2019","unstructured":"Otero MG, Tiongson E, Diaz F, Haude K, Panzer K, Collier A, Kim J, Adams D, Tifft CJ, Cui H, Millian Zamora F, Au MG, Graham JM Jr, Buckley DJ, Lewis R, Toro C, Bai R, Turner L, Mathews KD, Gahl W, Pierson TM (2019) Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy. Ann Clin Transl Neurol 6:154\u2013160","journal-title":"Ann Clin Transl Neurol"},{"key":"11200_CR120","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1093\/brain\/awaa279","volume":"143","author":"CH Lin","year":"2020","unstructured":"Lin CH, Tsai PI, Lin HY, Hattori N, Funayama M, Jeon B, Sato K, Abe K, Mukai Y, Takahashi Y, Li Y, Nishioka K, Yoshino H, Daida K, Chen ML, Cheng J, Huang CY, Tzeng SR, Wu YS, Lai HJ, Tsai HH, Yen RF, Lee NC, Lo WC, Hung YC, Chan CC, Ke YC, Chao CC, Hsieh ST, Farrer M, Wu RM (2020) Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy. Brain 143:3352\u20133373","journal-title":"Brain"},{"key":"11200_CR121","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mito.2020.11.005","volume":"56","author":"JQ Lu","year":"2021","unstructured":"Lu JQ, Tarnopolsky MA (2021) Mitochondrial neuropathy and neurogenic features in mitochondrial myopathy. Mitochondrion 56:52\u201361","journal-title":"Mitochondrion"},{"key":"11200_CR122","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-019-0372-4","volume":"51","author":"A Cortese","year":"2019","unstructured":"Cortese A, Simone R, Sullivan R, Vandrovcova J, Tariq H, Yau WY, Humphrey J, Jaunmuktane Z, Sivakumar P, Polke J, Ilyas M, Tribollet E, Tomaselli PJ, Devigili G, Callegari I, Versino M, Salpietro V, Efthymiou S, Kaski D, Wood NW, Andrade NS, Buglo E, Rebelo A, Rossor AM, Bronstein A, Fratta P, Marques WJ, Zuchner S, Reilly MM, Houlden H (2019) Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet 51:649\u2013658","journal-title":"Nat Genet"},{"key":"11200_CR123","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000436","volume":"6","author":"SM Boesch","year":"2020","unstructured":"Boesch SM, Nance MA (2020) Intronic pentanucleotide expansion in the replication factor 1 gene (RFC1) is a major cause of adult-onset ataxia. Neurol Genet 6:e436","journal-title":"Neurol Genet"},{"key":"11200_CR124","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/brain\/awz418","volume":"143","author":"A Cortese","year":"2020","unstructured":"Cortese A, Tozza S, Yau WY, Rossi S, Beecroft SJ, Jaunmuktane Z, Dyer Z, Ravenscroft G, Lamont PJ, Mossman S, Chancellor A, Maisonobe T, Pereon Y, Cauquil C, Colnaghi S, Mallucci G, Curro R, Tomaselli PJ, Thomas-Black G, Sullivan R, Efthymiou S, Rossor AM, Laura M, Pipis M, Horga A, Polke J, Kaski D, Horvath R, Chinnery PF, Marques W, Tassorelli C, Devigili G, Leonardis L, Wood NW, Bronstein A, Giunti P, Zuchner S, Stojkovic T, Laing N, Roxburgh RH, Houlden H, Reilly MM (2020) Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion. Brain 143:480\u2013490","journal-title":"Brain"},{"key":"11200_CR125","unstructured":"Cortese A, Reilly MM, Houlden H. RFC1 CANVAS\/Spectrum Disorder. 2020 Nov 25. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564656\/"},{"key":"11200_CR126","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/brain\/awab072","volume":"144","author":"R Curro","year":"2021","unstructured":"Curro R, Salvalaggio A, Tozza S, Gemelli C, Dominik N, Galassi Deforie V, Magrinelli F, Castellani F, Vegezzi E, Businaro P, Callegari I, Pichiecchio A, Cosentino G, Alfonsi E, Marchioni E, Colnaghi S, Gana S, Valente EM, Tassorelli C, Efthymiou S, Facchini S, Carr A, Laura M, Rossor AM, Manji H, Lunn MP, Pegoraro E, Santoro L, Grandis M, Bellone E, Beauchamp NJ, Hadjivassiliou M, Kaski D, Bronstein AM, Houlden H, Reilly MM, Mandich P, Schenone A, Manganelli F, Briani C, Cortese A (2021) RFC1 expansions are a common cause of idiopathic sensory neuropathy. Brain 144:1542\u20131550","journal-title":"Brain"},{"key":"11200_CR127","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1212\/CPJ.0000000000000215","volume":"6","author":"DJ Szmulewicz","year":"2016","unstructured":"Szmulewicz DJ, Roberts L, McLean CA, MacDougall HG, Halmagyi GM, Storey E (2016) Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Neurol Clin Pract 6:61\u201368","journal-title":"Neurol Clin Pract"},{"key":"11200_CR128","doi-asserted-by":"crossref","unstructured":"Traschutz A, Cortese A, Reich S, Dominik N, Faber J, Jacobi H, Hartmann AM, Rujescu D, Montaut S, Echaniz-Laguna A, Erer S, Schutz VC, Tarnutzer AA, Sturm M, Haack TB, Vaucamps-Diedhiou N, Puccio H, Schols L, Klockgether T, van de Warrenburg BP, Paucar M, Timmann D, Hilgers RD, Gazulla J, Strupp M, Moris G, Filla A, Houlden H, Anheim M, Infante J, Basak AN, Synofzik M, Group RFCS (2021) Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease. Neurology 96:e1369\u2013e1382","DOI":"10.1212\/WNL.0000000000011528"},{"key":"11200_CR129","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-021-00275-7","volume":"8","author":"L Kytovuori","year":"2022","unstructured":"Kytovuori L, Sipila J, Doi H, Hurme-Niiranen A, Siitonen A, Koshimizu E, Miyatake S, Matsumoto N, Tanaka F, Majamaa K (2022) Biallelic expansion in RFC1 as a rare cause of Parkinson\u2019s disease. NPJ Parkinsons Dis 8:6","journal-title":"NPJ Parkinsons Dis"},{"key":"11200_CR130","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/13854046.2016.1202239","volume":"30","author":"EE Robertson","year":"2016","unstructured":"Robertson EE, Hall DA, McAsey AR, O\u2019Keefe JA (2016) Fragile X-associated tremor\/ataxia syndrome: phenotypic comparisons with other movement disorders. Clin Neuropsychol 30:849\u2013900","journal-title":"Clin Neuropsychol"},{"key":"11200_CR131","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","volume":"79","author":"E Apartis","year":"2012","unstructured":"Apartis E, Blancher A, Meissner WG, Guyant-Marechal L, Maltete D, De Broucker T, Legrand AP, Bouzenada H, Thanh HT, Sallansonnet-Froment M, Wang A, Tison F, Roue-Jagot C, Sedel F, Charles P, Whalen S, Heron D, Thobois S, Poisson A, Lesca G, Ouvrard-Hernandez AM, Fraix V, Palfi S, Habert MO, Gaymard B, Dussaule JC, Pollak P, Vidailhet M, Durr A, Barbot JC, Gourlet V, Brice A, Anheim M (2012) FXTAS: new insights and the need for revised diagnostic criteria. Neurology 79:1898\u20131907","journal-title":"Neurology"},{"key":"11200_CR132","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-52014-2.00006-9","volume":"100","author":"SL Perlman","year":"2011","unstructured":"Perlman SL (2011) Spinocerebellar degenerations. Handb Clin Neurol 100:113\u2013140","journal-title":"Handb Clin Neurol"},{"key":"11200_CR133","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/mds.28307","volume":"35","author":"M Renaud","year":"2020","unstructured":"Renaud M, Tranchant C, Koenig M, Anheim M (2020) Autosomal recessive cerebellar ataxias with elevated alpha-fetoprotein: uncommon diseases, common biomarker. Mov Disord 35:2139\u20132149","journal-title":"Mov Disord"},{"key":"11200_CR134","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mds.26382","volume":"31","author":"C Lecocq","year":"2016","unstructured":"Lecocq C, Charles P, Azulay JP, Meissner W, Rai M, N\u2019Guyen K, Pereon Y, Fabre N, Robin E, Courtois S, Guyant-Marechal L, Zagnoli F, Rudolf G, Renaud M, Sevin-Allouet M, Lesne F, Alaerts N, Goizet C, Calvas P, Eusebio A, Guissart C, Derkinderen P, Tison F, Brice A, Koenig M, Pandolfo M, Tranchant C, Durr A, Anheim M (2016) Delayed-onset Friedreich\u2019s ataxia revisited. Mov Disord 31:62\u201369","journal-title":"Mov Disord"},{"key":"11200_CR135","doi-asserted-by":"crossref","unstructured":"Beaudin M, Manto M, Schmahmann JD, Pandolfo M, Dupre N (2022) Recessive cerebellar and afferent ataxias: clinical challenges and future directions. Nat Rev Neurol","DOI":"10.1038\/s41582-022-00634-9"},{"key":"11200_CR136","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0022-510X(02)00211-3","volume":"202","author":"PJ Garcia Ruiz","year":"2002","unstructured":"Garcia Ruiz PJ, Mayo D, Hernandez J, Cantarero S, Ayuso C (2002) Movement disorders in hereditary ataxias. J Neurol Sci 202:59\u201364","journal-title":"J Neurol Sci"},{"key":"11200_CR137","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/brain\/awp211","volume":"132","author":"M Anheim","year":"2009","unstructured":"Anheim M, Monga B, Fleury M, Charles P, Barbot C, Salih M, Delaunoy JP, Fritsch M, Arning L, Synofzik M, Schols L, Sequeiros J, Goizet C, Marelli C, Le Ber I, Koht J, Gazulla J, De Bleecker J, Mukhtar M, Drouot N, Ali-Pacha L, Benhassine T, Chbicheb M, M\u2019Zahem A, Hamri A, Chabrol B, Pouget J, Murphy R, Watanabe M, Coutinho P, Tazir M, Durr A, Brice A, Tranchant C, Koenig M (2009) Ataxia with oculomotor apraxia type 2: clinical, biological and genotype\/phenotype correlation study of a cohort of 90 patients. Brain 132:2688\u20132698","journal-title":"Brain"},{"key":"11200_CR138","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5334\/tohm.557","volume":"10","author":"JL Pedroso","year":"2020","unstructured":"Pedroso JL, Vale TC, da Costa SCG, Santos M, Alonso I, Barsottini OGP (2020) Complex movement disorders in ataxia with oculomotor apraxia type 1: beyond the cerebellar syndrome. Tremor Other Hyperkinet Mov (N Y) 10:39","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"11200_CR139","doi-asserted-by":"publisher","first-page":"125","DOI":"10.31083\/j.jin.2020.01.1239","volume":"19","author":"H Shimazaki","year":"2020","unstructured":"Shimazaki H, Kobayashi J, Sugaya R, Nakano I, Fujimoto S (2020) Late-onset autosomal recessive cerebellar ataxia and neuropathy with a novel splicing mutation in the ATM gene. J Integr Neurosci 19:125\u2013129","journal-title":"J Integr Neurosci"},{"key":"11200_CR140","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126:307\u2013328","journal-title":"Acta Neuropathol"},{"key":"11200_CR141","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/brain\/awu121","volume":"137","author":"V Pensato","year":"2014","unstructured":"Pensato V, Castellotti B, Gellera C, Pareyson D, Ciano C, Nanetti L, Salsano E, Piscosquito G, Sarto E, Eoli M, Moroni I, Soliveri P, Lamperti E, Chiapparini L, Di Bella D, Taroni F, Mariotti C (2014) Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain 137:1907\u20131920","journal-title":"Brain"},{"key":"11200_CR142","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000098","volume":"2","author":"J Hirst","year":"2016","unstructured":"Hirst J, Madeo M, Smets K, Edgar JR, Schols L, Li J, Yarrow A, Deconinck T, Baets J, Van Aken E, De Bleecker J, Datiles MB 3rd, Roda RH, Liepert J, Zuchner S, Mariotti C, De Jonghe P, Blackstone C, Kruer MC (2016) Complicated spastic paraplegia in patients with AP5Z1 mutations (SPG48). Neurol Genet 2:e98","journal-title":"Neurol Genet"},{"key":"11200_CR143","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/acn3.50860","volume":"6","author":"A Roubertie","year":"2019","unstructured":"Roubertie A, Charif M, Meyer P, Manes G, Meunier I, Taieb G, Junta Morales R, Guichet A, Delettre C, Sarzi E, Leboucq N, Rivier F, Lenaers G (2019) Hereditary spastic paraplegia and prominent sensorial involvement: think MAG mutations! Ann Clin Transl Neurol 6:1572\u20131577","journal-title":"Ann Clin Transl Neurol"},{"key":"11200_CR144","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/mds.23552","volume":"26","author":"A Guidubaldi","year":"2011","unstructured":"Guidubaldi A, Piano C, Santorelli FM, Silvestri G, Petracca M, Tessa A, Bentivoglio AR (2011) Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism. Mov Disord 26:553\u2013556","journal-title":"Mov Disord"},{"key":"11200_CR145","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/mds.27812","volume":"34","author":"B De la Casa-Fages","year":"2019","unstructured":"De la Casa-Fages B, Fernandez-Eulate G, Gamez J, Barahona-Hernando R, Moris G, Garcia-Barcina M, Infante J, Zulaica M, Fernandez-Pelayo U, Munoz-Oreja M, Urtasun M, Olaskoaga A, Zelaya V, Jerico I, Saez-Villaverde R, Catalina I, Sola E, Martinez-Saez E, Pujol A, Ruiz M, Schluter A, Spinazzola A, Munoz-Blanco JL, Grandas F, Holt I, Alvarez V, Lopez de Munain A (2019) Parkinsonism and spastic paraplegia type 7: expanding the spectrum of mitochondrial Parkinsonism. Mov Disord 34:1547\u20131561","journal-title":"Mov Disord"},{"key":"11200_CR146","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00415-009-0083-3","volume":"256","author":"M Anheim","year":"2009","unstructured":"Anheim M, Lagier-Tourenne C, Stevanin G, Fleury M, Durr A, Namer IJ, Denora P, Brice A, Mandel JL, Koenig M, Tranchant C (2009) SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol 256:104\u2013108","journal-title":"J Neurol"},{"key":"11200_CR147","doi-asserted-by":"publisher","first-page":"E376","DOI":"10.1002\/humu.20920","volume":"30","author":"C Goizet","year":"2009","unstructured":"Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, Stevanin G, Brice A (2009) Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat 30:E376-385","journal-title":"Hum Mutat"},{"key":"11200_CR148","doi-asserted-by":"crossref","unstructured":"Nemani T, Steel D, Kaliakatsos M, DeVile C, Ververi A, Scott R, Getov S, Sudhakar S, Male A, Mankad K, Genomics England Research C, Muntoni F, Reilly MM, Kurian MA, Carr L, Munot P (2020) KIF1A-related disorders in children: A wide spectrum of central and peripheral nervous system involvement. J Peripher Nerv Syst 25:117\u2013124","DOI":"10.1111\/jns.12368"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11200-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:19:26Z","timestamp":1744201166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11200-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":148,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11200"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11200-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}